<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03557476</url>
  </required_header>
  <id_info>
    <org_study_id>Octacosanol</org_study_id>
    <nct_id>NCT03557476</nct_id>
  </id_info>
  <brief_title>Effects of Octacosanol During Taekwondo Training</brief_title>
  <official_title>Octacosanol Supplementation Improves Lipid Profiles and Oxidative Stress During Rapid Weight Loss and High-Intensity Exercise in Taekwondo Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kosin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kosin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Taekwondo players undergo rapid reductions of body weight prior to their competition in order&#xD;
      to gain a size advantage over the opponent. However, these large weight changes with&#xD;
      concomitant high intensity exercise training induce poor lipid profiles and high levels of&#xD;
      oxidative stress, which can be detrimental to health and sports performance. Therefore, the&#xD;
      purpose of this study was to investigate the ability of the nutritional supplement&#xD;
      octacosanol to combat the physiological detriments that can occur from these rapid weight&#xD;
      changes paired with high intensity exercise training.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Athletes that participate in weight division sports such as taekwondo, boxing, judo, and&#xD;
      wrestling regularly reduce their body weight severely prior to competition in order to gain a&#xD;
      size advantage over the opponent while simultaneously meeting their weight division&#xD;
      requirements. In general, athletes have acute weight loss of 4-7 kg within 3-4 days of&#xD;
      competition, while longer periods of more gradual weight loss of 15-22 kg lasting 3-4 weeks.&#xD;
      Although this kind of extreme weight loss can induce metabolic dysfunction, it is repeatedly&#xD;
      performed by athletes of weight division sports in order to acquire a more advantageous&#xD;
      condition for play. Furthermore, athletes participating in matches tend to obtain excessive&#xD;
      weights compared to their weight division during the offseason in order to lift heavier&#xD;
      weights during training, and then rapidly lose that weight over a short period of time prior&#xD;
      to competition, resulting in the deterioration of physiological function and possibly sports&#xD;
      performance.&#xD;
&#xD;
      Rapid weight loss with high intensity exercise training also increases oxygen free radical&#xD;
      production to a point that exceeds the defense mechanism of antioxidant enzymes in the body&#xD;
      and ultimately results in damage to the cells, specifically, the lipid peroxidation of cell&#xD;
      membranes. Not only does this decrease physiological function, but sports performance can&#xD;
      also decrease as oxidative stress increases due to an interference in metabolic activity, a&#xD;
      reduction in vascular function and an increase in systemic inflammation. Octacosanol, a&#xD;
      straight-chain, high-molecular-weight, primary aliphatic alcohol minimally contained in the&#xD;
      germinal disks of rice bran, wheat and sugar cane, may be able to prevent these&#xD;
      deteriorations as it has been shown to provide various health benefits. In fact, previous&#xD;
      studies reported that pre-exercise octacosanol intake contributed to enhanced muscular&#xD;
      strength, muscular endurance and oxygen transport ability. Additionally, octacosanol&#xD;
      supplementation has been shown to improve cardiovascular endurance and heart function in&#xD;
      patients with peripheral artery disease, improve levels of low-density and high-density&#xD;
      lipoprotein-cholesterol in patients with hypercholesterolemia, and increase glycogen&#xD;
      accumulation in mice9. However, the potential beneficial effects of octacosanol intake for&#xD;
      reducing free radical production and preventing detrimental physiological function from&#xD;
      excessive weight loss with high intensity exercise has not been examined. Thus, the purpose&#xD;
      of this study was to investigate the effects of octacosanol supplementation during acute&#xD;
      weight loss with high-intensity exercise training on lipid profiles and markers of oxidative&#xD;
      stress in taekwondo players.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma triglyceride levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma total cholesterol levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High-density Lipoprotein</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of high-density lipoprotein</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low-density Lipoprotein</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of low-density lipoprotein</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of malondialdehyde</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superoxide Dismutase</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of superoxide dismutase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione Peroxidase</measure>
    <time_frame>6 days</time_frame>
    <description>Plasma levels of glutathione peroxidase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Octacosanol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Octacosanol</intervention_name>
    <description>One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
    <arm_group_label>Octacosanol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  at least 3 years of experience in national taekwondo competitions&#xD;
&#xD;
          -  abstain from caffeinated drinks, alcohol, and antioxidant supplements during the whole&#xD;
             period of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no history of chronic use of antioxidants, chronic aspirin, and nonsteroidal&#xD;
             anti-inflammatory drugs (NSAIDs)&#xD;
&#xD;
          -  No cardiovascular, neurological, metabolic or renal diseases&#xD;
&#xD;
          -  no musculoskeletal injuries&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Song Park, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska at Omaha</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <results_first_submitted>March 27, 2019</results_first_submitted>
  <results_first_submitted_qc>August 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2019</results_first_posted>
  <last_update_submitted>November 8, 2020</last_update_submitted>
  <last_update_submitted_qc>November 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kosin University</investigator_affiliation>
    <investigator_full_name>Sang-Ho Lee</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Octacosanol</keyword>
  <keyword>Taekwondo</keyword>
  <keyword>Lipid Profiles</keyword>
  <keyword>Oxidative Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT03557476/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18" spread="1"/>
                    <measurement group_id="B2" value="18" spread="1"/>
                    <measurement group_id="B3" value="18" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>South Korea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174.7" spread="1.4"/>
                    <measurement group_id="B2" value="173.9" spread="6.3"/>
                    <measurement group_id="B3" value="174.3" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.9" spread="6.7"/>
                    <measurement group_id="B2" value="66.7" spread="5.7"/>
                    <measurement group_id="B3" value="66.8" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body fat</title>
          <units>percentage of body fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" spread="2"/>
                    <measurement group_id="B2" value="8" spread="2"/>
                    <measurement group_id="B3" value="8" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Triglycerides</title>
        <description>Plasma triglyceride levels</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides</title>
          <description>Plasma triglyceride levels</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" spread="7.8"/>
                    <measurement group_id="O2" value="110" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Cholesterol</title>
        <description>Plasma total cholesterol levels</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol</title>
          <description>Plasma total cholesterol levels</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164" spread="12.8"/>
                    <measurement group_id="O2" value="173.5" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>High-density Lipoprotein</title>
        <description>Plasma levels of high-density lipoprotein</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>High-density Lipoprotein</title>
          <description>Plasma levels of high-density lipoprotein</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" spread="4.4"/>
                    <measurement group_id="O2" value="49.2" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Low-density Lipoprotein</title>
        <description>Plasma levels of low-density lipoprotein</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Low-density Lipoprotein</title>
          <description>Plasma levels of low-density lipoprotein</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.6" spread="8.1"/>
                    <measurement group_id="O2" value="114.9" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Malondialdehyde</title>
        <description>Plasma levels of malondialdehyde</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Malondialdehyde</title>
          <description>Plasma levels of malondialdehyde</description>
          <units>mmol/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.1"/>
                    <measurement group_id="O2" value="0.93" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Superoxide Dismutase</title>
        <description>Plasma levels of superoxide dismutase</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Superoxide Dismutase</title>
          <description>Plasma levels of superoxide dismutase</description>
          <units>U/gHb</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1450" spread="138.9"/>
                    <measurement group_id="O2" value="1010" spread="150.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glutathione Peroxidase</title>
        <description>Plasma levels of glutathione peroxidase</description>
        <time_frame>6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Octacosanol</title>
            <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
          </group>
        </group_list>
        <measure>
          <title>Glutathione Peroxidase</title>
          <description>Plasma levels of glutathione peroxidase</description>
          <units>U/gHb</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.9" spread="10.8"/>
                    <measurement group_id="O2" value="47.1" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Octacosanol</title>
          <description>Two capsules (20-mg x 2) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed daily by the octacosanol group for six days, one capsule 30 minutes after morning and afternoon meals.&#xD;
Octacosanol: One capsules (20-mg) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo ND, USA) was consumed twice a day</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>A placebo pill was taken twice daily in replacement of the octacosanol supplement&#xD;
Placebo: A placebo pill was taken twice a day in a double-blinded method at the same frequency and time as the octacosanol supplement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Song-Young Park</name_or_title>
      <organization>The University of Nebraska at Omaha</organization>
      <phone>402-554-3374</phone>
      <email>song-youngpark@unomaha.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

